Table 1.
Clinical features of the subjects with status epilepticus
| N | Percent | |||
|---|---|---|---|---|
| Sex | Female | 13 | 40.6 | |
| Male | 19 | 59.4 | ||
| Age [yr, median (range)] | 28.5 (16–81) | |||
| Etiology | infection | 16 | 50.0 | |
| vascular | 6 | 18.8 | ||
| neoplasm | 1 | 3.1 | ||
| unknown | 9 | 28.1 | ||
| Status epilepticus | ESE | 11 | 34.4 | |
| RSE | 21 | 65.5 | ||
| RSE-P | 13 | 61.9 | ||
| RSE-O | 8 | 38.1 | ||
| Hospital stays [d, median (range)] | 12.5 (2–240) | |||
| Outcome | return to baseline | 8 | 25.0 | |
| no return to baseline | 15 | 46.9 | ||
| death | 9 | 28.1 | ||
| Previous epilepsy | 10 | 31.3 | ||
*
ESS: established status epilepticus, RSE-P/O: refractory status epilepticus, treated with propofol/the other anesthetics.